Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 5NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 9Other hematologic neoplasm 8Genitourinary 7Breast 6Thoracic 4Gastrointestinal 3CNS 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Head & Neck 1Gynecologic 1Endocrine 1Dermatologic 1

Conditions

Neoplasms, Plasma Cell 1Multiple Myeloma 1

Interventions

Dexamethasone 48Bortezomib 22Lenalidomide 20Cyclophosphamide 20daratumumab 18Calcium Dobesilate 15Melphalan 13Thalidomide 12carfilzomib 9pomalidomide 7Prednisone 7dexamethasone acetate 6dexamethasone 21-phosphate 6auricularum 6Peripheral Blood Stem Cell Transplantation 6Doxorubicin 6isatuximab 5Filgrastim 5Vincristine 4Interferon-alpha 3Etoposide 3selinexor 2sargramostim 2ixazomib 2elotuzumab 2cobimetinib 2belantamab mafodotin 2Steroids 2Stem Cell Transplantation 2Radiotherapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Amplified Fragment Length Polymorphism Analysis × Plasma cell × Clear all
NCT00898040 2017-05-19

Study of DNA Samples From Patients With Multiple Myeloma

Eastern Cooperative Oncology Group

Completed
600 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡